BCM
MBOT icon

Bridgeway Capital Management’s Microbot Medical MBOT Stock Holding History

Bridgeway Capital Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$86.4K Sell
44,300
-50,000
-53% -$102K ﹤0.01% 1158
2026
Q1 		$227K Sell
94,300
-16,700
-15% -$37.3K ﹤0.01% 1005
2025
Q4 		$222K Buy
+111,000
New +$263K ﹤0.01% 997

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Bridgeway Capital Management's MBOT Position: Q2 2026 in Review

Bridgeway Capital Management reduced its Microbot Medical (MBOT) stake by 53% in Q2 2026, selling an estimated $102K and leaving 44,300 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1158.

Bridgeway Capital Management first reported a position in MBOT in Q4 2025 and has held it in 3 quarters since. The position peaked at $227K in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Bridgeway Capital Management held 44,300 shares of Microbot Medical worth $86.4K as of Q2 2026.
  • Bridgeway Capital Management sold 50,000 Microbot Medical shares in Q2 2026, an estimated $102K.
  • Microbot Medical made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #1158 holding.
  • Bridgeway Capital Management first reported a position in Microbot Medical in Q4 2025 and has held it in 3 quarters since.
  • Bridgeway Capital Management's Microbot Medical position peaked at $227K in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.